Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Immunopharmacology|September 1, 1981
Murine macrophage cytotoxicity induced by mastocytoma cells, cell-free mastocytoma exudates, and extractsH F Dullens, W Den OtterImmunopharmacology|December 1, 1981
A small molecular weight peptide from P815 mastocytoma cells induces macrophage cytotoxicityH F Dullens, W den OtterCancer Immunology, Immunotherapy : CII|January 1, 1990
Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity systemD Characiejus, H F Dullens, W Den OtterExperimental Pathology|January 1, 1987
Spontaneous tumor rejection is not always due to a complete cellular rejectionH F Dullens, S Schakenrad, W Den OtterStrahlentherapie|June 1, 1979
Influence of whole body irradiation on intraperitoneal immunity in a syngeneic mouse lymphoma systemH F Dullens, H Bouman, W Den OtterCancer Immunology, Immunotherapy : CII|January 1, 1993
Interleukin-2 in cancer treatment: disappointing or (still) promising? A reviewR A Maas, H F Dullens, W Den OtterIn Vivo (Athens, Greece)|November 1, 1991
Mechanisms of tumor regression induced by low doses of interleukin-2R A Maas, H F Dullens, W Den OtterCancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F DullensAnticancer Research|January 1, 1996
The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activityH Voshol, H F Dullens, W Den Otter, et al.Pageof 18